Trials / Completed
CompletedNCT03017703
The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes
The Role of Aldosterone in Diabetes Related Vascular Disease, a New Therapeutic Target?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University of Southern Denmark · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The importance of Aldosterone for endothelial function and Insulin resistance observed within patients with type 2 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eplerenone |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-10-01
- Completion
- 2019-12-15
- First posted
- 2017-01-11
- Last updated
- 2021-06-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03017703. Inclusion in this directory is not an endorsement.